ELISMETREP
Elismetrep is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target transient receptor potential cation channel subfamily M member 8.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
11 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hot flashes | D019584 | — | — | 1 | 2 | — | — | — | 3 |
| Pain | D010146 | EFO_0003843 | R52 | — | 2 | — | — | — | 2 |
| Peripheral nervous system diseases | D010523 | — | G64 | — | 2 | — | — | — | 2 |
| Diabetic neuropathies | D003929 | EFO_1000783 | — | — | 2 | — | — | — | 2 |
| Migraine disorders | D008881 | EFO_0003821 | G43 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 5 | — | — | — | — | 5 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | ELISMETREP |
| INN | elismetrep |
| Description | Elismetrep is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target transient receptor potential cation channel subfamily M member 8. |
| Classification | Small molecule |
| Drug class | antagonists of the transient receptor potential channel (TRP), melatsatin (TRPM) type; transient receptor potential antagonists |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=C(O)c1ccc(S(=O)(=O)N(Cc2ccc(OC(F)(F)F)cc2)c2ncc3ccccc3c2C2CC2)cc1 |
Identifiers
| PDB | — |
| CAS-ID | 1400699-64-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3682589 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | KIB8V5UR7D (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
TRPM8
TRPM8
Organism
Homo sapiens
Gene name
TRPM8
Gene synonyms
LTRPC6, TRPP8
NCBI Gene ID
Protein name
transient receptor potential cation channel subfamily M member 8
Protein synonyms
Long transient receptor potential channel 6, LTrpC-6, LTrpC6, Transient receptor potential p8, transient receptor potential subfamily M member 8, Trp-p8, TRPM8 cationic channel
Uniprot ID
Mouse ortholog
Trpm8 (171382)
transient receptor potential cation channel subfamily M member 8 (Q8R4D5)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use